Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Foam corticosteroid covers as well as traditional forms.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Lipid nanocarriers could effectively promote hair regrowth with fewer side effects.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Early diagnosis and comprehensive management improve life quality for Netherton syndrome patients.

ADSC-enriched fat grafting is the best and safest aesthetic treatment, combining effectiveness and ethical confidence.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Botulinum toxins effectively treat excessive sweating and may help with other skin conditions, but more research is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.